Skip to content

Research at St Andrews

ASS234, as a new Multi-Target Directed propargylamine for Alzheimer’s disease therapy

Research output: Contribution to journalReview article

Author(s)

José Marco-Contelles, Mercedes Unzeta, Gerard Esteban, Rona Ramsay, Alejandro Romero, Ricardo Martínez-Murillo, Maria C. Carreiras, Lhassane Ismaili, Irene Bolea

School/Research organisations

Abstract

The complex nature of Alzheimer’s disease (AD) has prompted the design of Multi-Target-Directed Ligands (MTDL) able to bind to diverse biochemical targets involved in the progress and development of the disease. In this context, we have designed a number of MTD propargylamines showing antioxidant, anti-betaamyloid, anti-inflammatory, as well as cholinesterase and monoamine oxidase inhibition capacities. Here, we describe these properties in the MTDL ASS234, our lead-compound ready to enter in pre-clinical studies for AD, as a new multipotent, permeable cholinesterase/monoamine oxidase inhibitor, able to inhibit Aβ- aggregation, possessing antioxidant and neuroprotective properties.
Close

Details

Original languageEnglish
Article number294
Number of pages7
JournalFrontiers in Neuroscience
Volume10
DOIs
Publication statusPublished - 28 Jun 2016

    Research areas

  • Multi-target directed ligands, Alzheimer’s disease, Monomaine oxidases, Cholinesterases, Drugs

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Synthesis, biological evaluation, and molecular modeling of nitrile-containing compounds: exploring multiple activities as anti-Alzheimer agents

    Silva, D., Mendes, E., Summers, E. J., Neca, A., Jacinto, A. C., Reis, T., Agostinho, P., Bolea, I., Jimeno, M. L., Mateus, M. L., Oliveira-Campos, A. M. F., Unzeta, M., Marco-Contelles, J., Majekova, M., Ramsay, R. R. & Carreiras, M. C., 30 Aug 2019, In : Drug Development Research. Early View, DDR-19-0121.R1.

    Research output: Contribution to journalArticle

  2. Electron carriers and energy conservation in mitochondrial respiration

    Ramsay, R. R., Jun 2019, In : ChemTexts. 5, 14 p., 9.

    Research output: Contribution to journalArticle

  3. Molecular aspects of the activity and inhibition of the FAD-containing monoamine oxidases

    Ramsay, R. R., 31 Mar 2019, Pharmaceutical Biocatalysis: Fundamentals, Enzyme Inhibitors, and Enzymes in Health and Diseases . Grunwald, P. (ed.). Singapore: Pan Stanford Publishing Pte. Ltd., Vol. 4. (Series on Biocatalysis; vol. 4, no. 10).

    Research output: Chapter in Book/Report/Conference proceedingChapter

  4. Kinetics, mechanism and inhibition of monoamine oxidase

    Ramsay, R. R. & Albreht, A., Nov 2018, In : Journal of Neural Transmission. 125, 11, p. 1659–1683 25 p.

    Research output: Contribution to journalReview article

  5. Evidence for a cyanine link between propargylamine drugs and monoamine oxidase clarifies the inactivation mechanism

    Albreht, A., Vovk, I., Mavri, J., Marco-Contelles, J. & Ramsay, R. R., 28 May 2018, In : Frontiers in Chemistry. 6, 11 p., 169.

    Research output: Contribution to journalArticle

Related by journal

  1. Identifying cortical substrates underlying the phenomenology of stereopsis and realness: a pilot fMRI study

    Uji, M., Lingnau, A., Cavin, I. & Vishwanath, D., 11 Jul 2019, In : Frontiers in Neuroscience. 13, 14 p., 646.

    Research output: Contribution to journalArticle

  2. All-optical assay to study biological neural networks

    Afshar Saber, W., Gasparoli, F. M., Dirks, M. G., Gunn-Moore, F. J. & Antkowiak, M., 5 Jul 2018, In : Frontiers in Neuroscience. 12, 12 p., 451.

    Research output: Contribution to journalArticle

  3. Facial shape analysis identifies valid cues to aspects of physiological health in Caucasian, Asian and African populations

    Stephen, I. D., Hiew, V., Coetzee, V., Tiddeman, B. & Perrett, D. I., 30 Oct 2017, In : Frontiers in Neuroscience. 8, 1883.

    Research output: Contribution to journalArticle

  4. Drug design for CNS diseases: polypharmacological profiling of compounds using cheminformatic, 3D-QSAR and virtual screening methodologies

    Nikolic, K., Mavridis, L., Djikic, T., Vukicevic, J., Agbaba, D., Yelekci, K. & Mitchell, J. B. O., 10 Jun 2016, In : Frontiers in Neuroscience. 10, p. 18-38 21 p., 265.

    Research output: Contribution to journalArticle

ID: 243265429

Top